Clinical Trial Update: A Crossover Bioavailability Clinical Trial of Parenteral Pyronaridine and Artesunate [Phase 1, Phase 2]

View source ↗

Summary

A crossover bioavailability study of parenteral pyronaridine and artesunate is being conducted in Phase 1 and Phase 2 for severe malaria treatment; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Artesunate (artesunate)
• Pyronaridine (pyronaridine)

Snippet

Sponsor: Centre de Recherche Médicale de Lambaréné | Conditions: Severe Malarial Treatment | Phase 1, Phase 2 | Status: UNKNOWN